Alan J. Smith

521 total citations
10 papers, 410 citations indexed

About

Alan J. Smith is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Alan J. Smith has authored 10 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Alan J. Smith's work include Cytokine Signaling Pathways and Interactions (3 papers), Acute Myeloid Leukemia Research (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Alan J. Smith is often cited by papers focused on Cytokine Signaling Pathways and Interactions (3 papers), Acute Myeloid Leukemia Research (2 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Alan J. Smith collaborates with scholars based in United States, Canada and France. Alan J. Smith's co-authors include Amy E. Lovett‐Racke, Michael K. Racke, Yuhong Yang, Yue Liu, Haiyan Peng, David Huss, Petra D. Cravens, Jeffrey L. Weiner, Ryan C. Winger and Yue Liu and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Diabetes.

In The Last Decade

Alan J. Smith

7 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan J. Smith United States 6 275 71 71 68 49 10 410
Tim Lentini United States 9 341 1.2× 107 1.5× 75 1.1× 55 0.8× 17 0.3× 9 512
Kwon Ik Oh South Korea 11 323 1.2× 227 3.2× 96 1.4× 57 0.8× 26 0.5× 16 592
Chuandong Wei China 12 103 0.4× 71 1.0× 25 0.4× 46 0.7× 64 1.3× 17 310
Atsuko Asao Japan 9 157 0.6× 87 1.2× 59 0.8× 15 0.2× 69 1.4× 17 335
Adeleye Opejin United States 8 251 0.9× 79 1.1× 62 0.9× 21 0.3× 13 0.3× 9 372
F Pawlak Germany 5 161 0.6× 56 0.8× 29 0.4× 73 1.1× 48 1.0× 6 343
Selin Gencer Germany 10 170 0.6× 132 1.9× 78 1.1× 14 0.2× 71 1.4× 14 375
Dae‐Weon Park South Korea 13 153 0.6× 172 2.4× 42 0.6× 18 0.3× 46 0.9× 16 371
Seung Ah Yoo South Korea 7 117 0.4× 119 1.7× 41 0.6× 16 0.2× 35 0.7× 16 341
Madelene Lindkvist Sweden 5 97 0.4× 101 1.4× 69 1.0× 17 0.3× 28 0.6× 8 313

Countries citing papers authored by Alan J. Smith

Since Specialization
Citations

This map shows the geographic impact of Alan J. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan J. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan J. Smith more than expected).

Fields of papers citing papers by Alan J. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan J. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan J. Smith. The network helps show where Alan J. Smith may publish in the future.

Co-authorship network of co-authors of Alan J. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Alan J. Smith. A scholar is included among the top collaborators of Alan J. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan J. Smith. Alan J. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bradley, David, Joey Z. Liu, Valerie P. Wright, et al.. (2025). The GLP-1 Receptor Agonist Dulaglutide Attenuates Hepatic Steatosis in Obesity via a Weight-Independent Mechanism. Diabetes. 74(9). 1512–1524.
2.
Bradley, David, Alan J. Smith, Alecia Blaszczak, et al.. (2022). Interferon gamma mediates the reduction of adipose tissue regulatory T cells in human obesity. Nature Communications. 13(1). 5606–5606. 57 indexed citations
3.
Bradley, David, et al.. (2021). Adipose Tissue T Regulatory Cells: Implications for Health and Disease. Advances in experimental medicine and biology. 1278. 125–139. 9 indexed citations
4.
Smith, Alan J., et al.. (2017). IL-23R–activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity. JCI Insight. 2(17). 71 indexed citations
5.
Smith, Alan J.. (2011). IL-23 Receptor Expression and Effects of Signaling on T Cell Encephalitogenicity. OhioLink ETD Center (Ohio Library and Information Network).
6.
Smith, Alan J., et al.. (2011). Comparison of a classical Th1 bacteria versus a Th17 bacteria as adjuvant in the induction of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 237(1-2). 33–38. 6 indexed citations
7.
Yang, Yuhong, Jeffrey L. Weiner, Yue Liu, et al.. (2009). T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. The Journal of Experimental Medicine. 206(7). 1549–1564. 224 indexed citations
8.
Liesveld, Jane L., Camille N. Abboud, Chaohui Lü, et al.. (2003). Flavonoid effects on normal and leukemic cells. Leukemia Research. 27(6). 517–527. 42 indexed citations
9.
Liesveld, Jane L., et al.. (2000). Effects of anti-oxidants on normal and leukemic hematopoiesis. Experimental Hematology. 28(7). 126–126. 1 indexed citations
10.
Purcell, Edward M. & Alan J. Smith. (1986). Electricity and Magnetism. American Journal of Physics. 54(3). 287–287.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026